EUVIMEDEUVIMED entdecken
Crossref

Lenvatinib delivery using a Gd/Fe bimetallic MOF: Enhancing antitumor immunity following microwave-based thermal therapy

Qiaozheng Wang, Xiaowen Zhu, Xianwei Meng, Hongshan Zhong

Acta Biomaterialia · 2023-12 · 172 · 382-394

DOI: 10.1016/j.actbio.2023.09.052 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biomaterialia, 2023-12. Verfasst von Qiaozheng Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Interventional Radiology, The First Hospital of China Medical University, No.155 Nanjing North Street, Shenyang, 110001, Liaoning, Peop…. Hauptthemen laut MEDLINE: B7-H1 Antigen, Neoplasms. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Liaoning Revitalization Talents Program, National Natural Science Foundation of China, Ministry of Science and Technology of the People's Republic of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Microwave (MW) thermal therapy has been developed as an effective clinical strategy that can achieve pronounced antitumor activity and also has the potential to trigger antitumor immunity. However, patients generally face high rates of tumor recurrence following MW treatment, limiting the long-term benefits of such treatment. The combination of MW treatment and immunomodulatory strategies may represent a promising means of reprogramming the immunosuppressive tumor microenvironment (TME) in a manner conducive to lower recurrence rates. In this study, a Lenvatinib-loaded Gd/Fe metal-organic framework (Gd/FeMOF) was designed as a promising approach to enhancing such antitumor immunity. MW-enhanced dynamic Gd/FeMOF sensitization can facilitate high levels of reactive oxygen species production under MW irradiation, resulting in stronger immunogenic tumor cell death. In parallel, the Lenvatinib released from Gd/FeMOF preparations can serve as an immune adjuvant that suppresses programmed death ligand 1 (PD-L1) expression and drives the reprogramming of the immunosuppressive TME. The Gd and Fe present within this MOF preparation also imbue it with magnetic resonance imaging capabilities. Importantly, in vivo animal model experiments confirmed the ability of GdFeMOF treatment to significantly enhance antitumor immunity while protecting against recurrence. Accordingly, this study offers a foundation for promising strategies aimed at the integrated diagnosis and durable treatment of cancer. STATEMENT OF SIGNIFICANCE: High rates of tumor recurrence following MW thermal therapy limit the long-term benefits of such treatment. We found that the administration of Lenvatinib-loaded Gd/FeMOF nanoparticles significantly reduced tumor recurrence after MW thermal therapy. Under MW irradiation, the Gd/FeMOF nanoparticles were found to augment the immune response due to facilitation of the process of immunogenic cell death. In addition, the released Lenvatinib could act as an immune adjuvant to downregulate the expression of PD-L1 and reprogram the immunosuppressive state of the tumor microenvironment, thus further enhancing the immune response. This is significant because MW-induced immune responses are relatively weak and usually fail to effectively prevent tumor recurrence. The combination of MW treatment with an immunomodulatory strategy may solve this problem.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

B7-H1 AntigenNeoplasmsAnimalsHumansMicrowavesNeoplasm Recurrence, LocalCell Line, TumorTumor MicroenvironmentPhenylurea CompoundsQuinolines

Stichwörter der Autor:innen

Gd/Fe metal-organic framework (Gd/Fe MOF)Lenvatinib (LEN)Microwave (MW) thermal therapyMicrowave-enhanced dynamic therapy (MEDT)Programmed death ligand 1 (PD-L1)

Substanzen

B7-H1 AntigenlenvatinibPhenylurea CompoundsQuinolines

Autor:innen und Institutionen

  • Department of Interventional Radiology, The First Hospital of China Medical University, No.155 Nanjing North Street, Shenyang, 110001, Liaoning, People's Republic of China.
  • Laboratory of Controllable Preparation and Application of Nanomaterials, Key Laboratory of Cryogenics, Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, No.29 East Road Zhongguancun, Beijing 100…
  • Department of Interventional Radiology, The First Hospital of China Medical University, No.155 Nanjing North Street, Shenyang, 110001, Liaoning, People's Republic of China. Electronic address: hszhong@cmu.edu.cn.

Förderung

  • Liaoning Revitalization Talents Program
  • National Natural Science Foundation of China
  • Ministry of Science and Technology of the People's Republic of China

Zitieren

APA

Wang, Q., Zhu, X., Meng, X., & Zhong, H. (2023). Lenvatinib delivery using a Gd/Fe bimetallic MOF: Enhancing antitumor immunity following microwave-based thermal therapy. Acta Biomaterialia, 172, 382-394. https://doi.org/10.1016/j.actbio.2023.09.052

Vancouver

Wang Q, Zhu X, Meng X, Zhong H. Lenvatinib delivery using a Gd/Fe bimetallic MOF: Enhancing antitumor immunity following microwave-based thermal therapy. Acta Biomaterialia. 2023;172:382-394. doi:10.1016/j.actbio.2023.09.052

BibTeX
@article{Wang2023,
  author = {Wang, Qiaozheng and Zhu, Xiaowen and Meng, Xianwei and Zhong, Hongshan},
  title = {Lenvatinib delivery using a Gd/Fe bimetallic MOF: Enhancing antitumor immunity following microwave-based thermal therapy},
  journal = {Acta Biomaterialia},
  year = {2023},
  volume = {172},
  pages = {382--394},
  doi = {10.1016/j.actbio.2023.09.052}
}
Kostenlos starten →